Integra LifeSciences Announces Participation in Upcoming Investor Conferences

September 2, 2021 4:01 PM EDT

PRINCETON, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:

  • On September 9, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Wells Fargo 2021 Virtual Healthcare Conference at 11:20am ET.
  • On September 13, 2021, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley 19th Annual Global Healthcare Conference at 1:15pm ET.

Webcast information can be found on the Company’s website at Investor Relations.

About Integra LifeSciencesIntegra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, MatriStem® UBM, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.

Investor Relations: Michael Beaulieu(609) 529-4812[email protected]  

Media Contact: Laurene Isip (609) 208-8121[email protected]

Primary Logo

Source: Integra LifeSciences Holdings Corporation


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Globe Newswire, Press Releases

Related Entities

Morgan Stanley, Wells Fargo